about
Doubly robust estimation of causal effectsUsing claims data to predict dependency in activities of daily living as a proxy for frailty.Nonexperimental comparative effectiveness research using linked healthcare databasesValidation of Medicaid Claims-based Diagnosis of Myocardial Infarction Using an HIV Clinical CohortPropensity score methods for confounding control in nonexperimental researchTrends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011The role of the c-statistic in variable selection for propensity score models.Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailtyIncreasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial resultsEvidence of sample use among new users of statins: implications for pharmacoepidemiology.The role of prediction modeling in propensity score estimation: an evaluation of logistic regression, bCART, and the covariate-balancing propensity scoreReducing Bias Amplification in the Presence of Unmeasured Confounding Through Out-of-Sample Estimation Strategies for the Disease Risk Score.Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly.Variable selection for propensity score modelsPatterns of rotavirus vaccine uptake and use in privately-insured US infants, 2006-2010.Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example.Model Misspecification When Excluding Instrumental Variables From PS Models in Settings Where Instruments Modify the Effects of Covariates on TreatmentThe implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration.Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.Comparative Safety of Testosterone Dosage Forms.Misinterpretation of the Comparative Safety of Testosterone Dosage Forms-ReplyEffect of statin use on acute kidney injury risk following coronary artery bypass grafting.Matching on the disease risk score in comparative effectiveness research of new treatmentsCalendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis.Acute kidney injury in statin initiators.Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011.Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010.Short look-back periods in pharmacoepidemiologic studies of new users of antibiotics and asthma medications introduce severe misclassification.Confounding control in healthcare database research: challenges and potential approaches.Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes.Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study.Injection Testosterone and Adverse Cardiovascular Events: A Case-crossover Analysis.Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety DisordersApproaches to Address Premature Death of Patients When Assessing Patterns of Use of Health Care Services After an Index EventCause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypesEffect of Initiating Cardiac Rehabilitation After Myocardial Infarction on Subsequent Hospitalization in Older AdultsPsychotherapy Claims Surrounding Pharmacotherapy Initiation in Children and Adolescents with Anxiety Disorders
P50
Q30499313-F4E7668F-1201-4A45-B955-4F416E49C8C0Q30863566-2C300910-F3EA-4A37-B480-DF085DEE8A97Q33576469-4EFF0085-720B-4848-A807-55DDDE27B43EQ33618727-2201E6CD-D5A0-4802-9FA7-534B1C482B64Q33654170-BEAE8258-F1C8-4005-891A-D2FF87FCD1E6Q33821627-6B1A134B-5AF4-4F0E-ABF1-67145295656DQ33829788-E9E1B362-A7C3-4739-823F-8E51527E7C5AQ33847653-E93E17EF-FFC2-40F1-9E3C-51D6E6A827ABQ33866201-03690CA3-6180-4063-80BB-B6C45EB87E7FQ34001872-C1F9FA8B-C79B-4FBC-B0FA-49E6A712EAD0Q34077639-9C6FDE79-61DF-4A1C-B8EF-B1E51BE6A06AQ34149360-C1EA2A83-0422-4211-AA8E-4D3E49344DD1Q34323908-FA664554-B68C-4A62-A970-A3EED12D8E67Q34463743-12E495DE-D870-4ED7-85A0-4414170AF1B9Q34803815-778BCF48-BED4-4866-B186-CD3468BBBC46Q34997107-E9A263B3-6ED3-4C02-8AB6-0A7AB1D0C621Q35045666-1EBA3679-456B-4793-9C78-ABA85F1F7FFAQ35056126-F2391FE4-DB4F-4C20-BBB1-1CC6F0838DD7Q35068828-668B6FFF-7C8E-41BB-ACE9-572737FECA21Q35774970-5BE471CC-4C50-4C17-9BAF-763564E4D549Q35828716-32008C20-180C-4AA9-A59A-373D48E58C14Q36693955-2732E2BC-309C-42BD-B342-DEAEA6B5904DQ36799968-24DB6ADA-B08A-4588-B600-EFC2987C4CE7Q36802843-AD06D257-E1BB-4B54-A438-E8E806598E64Q36859634-E4FFA5A4-8332-42C1-8FBE-1CC1B6A84CDBQ37000713-E0446EAB-3638-4FBE-A761-6C9C8B1BCA67Q37293690-F2F44006-0A2C-4261-BCCB-D69F7EC517E4Q37616874-194A9C2D-6535-482D-8E60-8C53D9968BA7Q37671911-E718934B-1AEB-44E9-ABA7-123F49018E4BQ38324101-81BC8E05-AC17-4BE5-8BF3-42194420B316Q39700269-732DF7BD-8469-43A4-B7A5-F179F55A2107Q41141330-CDEAD13F-7653-4427-AA2F-909FD574FAD0Q48099656-6123EEC1-C438-4D55-AE77-12F52C4C98D9Q49985009-BCE8AFF3-2AEC-4CDE-B76D-4DB61D76A8BEQ52816425-89DE6D81-19AD-4E08-BF57-19FAF8022A7FQ88397598-A3BE3966-F51F-4913-A77E-63A866E2E87AQ89021710-D0651F9B-EC6D-4BDE-8423-626275AC988FQ90476295-D05775A6-E7C5-4F1D-B8F3-D80A5F8E2CC4Q90586442-FA67DBED-A58E-4C8A-8B1F-8B664BB6A56BQ90632169-E44943B1-023B-46F4-A18A-CA7DD5CD1C72
P50
name
M Alan Brookhart
@en
M Alan Brookhart
@nl
type
label
M Alan Brookhart
@en
M Alan Brookhart
@nl
prefLabel
M Alan Brookhart
@en
M Alan Brookhart
@nl